scispace - formally typeset
E

Eva Harris

Researcher at University of California, Berkeley

Publications -  357
Citations -  26475

Eva Harris is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Dengue virus & Dengue fever. The author has an hindex of 84, co-authored 332 publications receiving 22718 citations.

Papers
More filters
Journal ArticleDOI

Development of an Internally Controlled Real-Time Reverse Transcriptase PCR Assay for Pan-Dengue Virus Detection and Comparison of Four Molecular Dengue Virus Detection Assays

TL;DR: The design of an internally controlled real-time reverse transcriptase PCR (rRT-PCR) that detects all four DENV serotypes but does not distinguish between them is reported, which is believed to serve to lengthen the period during which a confirmed molecular diagnosis of DENV infection can be provided.
Journal ArticleDOI

Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika.

TL;DR: Assessment of the memory B cell (MBC) and antibody response to Zika virus (ZIKV) in individuals with and without prior dengue virus (DENV) infection finds that ZIKV infection elicits a robust and specific MBC response that is only modestly affected by the number of prior DENV infections.
Journal ArticleDOI

Clinical evaluation of a single-reaction real-time RT-PCR for pan-dengue and chikungunya virus detection

TL;DR: The single-reaction, multiplex format of the pan-DENV-CHIKV rRT-PCR, combined with sensitive detection of both viruses, has the potential to improve detection while decreasing testing costs and streamlining molecular workflow.
Journal ArticleDOI

Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitions.

TL;DR: Interestingly, despite containing less symptoms that cannot be readily expressed by children aged less than 4 years, the revised case definition did not perform better in this age group, indicating that both case definitions have similar capacity to diagnose dengue.
Journal ArticleDOI

Liposome mediated delivery of iminosugars enhances efficacy against dengue virus in vivo

TL;DR: Liposome-mediated delivery of NB-DNJ, in comparison with free NB- DNJ, resulted in a 3-log10 reduction in the dose of drug sufficient to enhance animal survival, which could liberate the therapeutic potential of many cytotoxic antivirals against both dengue virus and a wide array of other viruses.